Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Jun Liu

Dr Jun Liu

Jun Liu



After completing my clinical medicine degree at Shanghai Jiao Tong University in China in 2013, I gained experience in the clinical epidemiology of type 2 diabetes through a one-year research placement at Rui-Jin Hospital's Department of Endocrine and Metabolic Diseases in Shanghai. I then advanced my education with an MSc in genetic epidemiology from the Erasmus Medical Center in Rotterdam, Netherlands. My academic journey continued, culminating in a PhD with my thesis on "Integration of Multi-Omics in Type 2 Diabetes and Related Disorders Research."

In 2019, I relocated to Oxford to join the Nuffield Department of Population Health at the University of Oxford as a postdoctoral researcher, focusing on multi-omics data integration for cardiometabolic and neurological disorders.

Starting September 2021, I have been honored to work as a Novo Nordisk Research Fellow alongside Professor Cornelia van Duijn (NDPH) and Dr Joanna Howson (Novo Nordisk Research Centre Oxford). The project, "An Integrative Cross-omics Study of Non-Alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis," has led me to explore omics profiles and identify potential drug targets for NAFLD using proteomics, alongside integrating additional omics data.

In 2023, I achieved full registration with the General Medical Council (GMC) in the UK.